Oak Ridge Investments LLC Viking Therapeutics, Inc. Transaction History
Oak Ridge Investments LLC
- $1.25 Billion
- Q4 2024
A detailed history of Oak Ridge Investments LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Oak Ridge Investments LLC holds 11,022 shares of VKTX stock, worth $359,868. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,022
Previous 13,222
16.64%
Holding current value
$359,868
Previous $837,000
47.07%
% of portfolio
0.04%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
476Shares Held
63.4MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$197 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$153 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$69.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$61.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.5B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...